GlassScriptPhysician profile
Christine S Buono
NPI 1245263516
$2,093.51
in general payments reported to CMS, 2019-2025
19 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $182 · 2021: $655 · 2022: $571 · 2023: $102 · 2024: $190 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $437.50 | 2019-2022 | |
| Allergan, INC. | $272.06 | 2019-2022 | |
| Alcon Vision LLC | $206.20 | 2019-2023 | Rocklatan |
| Biogen, INC. | $176.15 | 2021-2023 | Tysabri |
| Novartis Pharmaceuticals Corporation | $147.74 | 2019-2022 | |
| Oyster Point Pharma, INC. | $140.30 | 2022 | |
| Amgen INC. | $124.99 | 2024 | Tepezza |
| Glaukos Corporation | $121.02 | 2021 | |
| Sun Pharmaceutical Industries INC. | $89.73 | 2020-2025 | |
| Mallinckrodt Hospital Products INC. | $65.64 | 2020 | |
| Mallinckrodt Enterprises LLC | $62.77 | 2019 | |
| Bausch & Lomb Americas INC. | $57.42 | 2024-2025 | Miebo, Vyzulta, Doctors Allergy Formula |
| Harrow Eye, LLC | $49.47 | 2024 | Iheezo, Triesence, Vevye |
| Abbvie INC. | $34.47 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $27.82 | 2025 | Xdemvy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22.66 | 2021 | |
| Biotissue Holdings INC. | $22.32 | 2020 | |
| Dompe US, INC. | $19.47 | 2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $15.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Buono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.